Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Androsorb cleared for clinical trials

Dec. 23, 1996

ImClone and Immunex crosslicense flt3/flk-2 technology

Dec. 23, 1996

Third approval for Parke-Davis HMG-CoA reductase inhibitor

Dec. 23, 1996

Fujisawa synthesizes novel bone resorption inhibitors

Dec. 20, 1996

Grelan, Fournier collaborate on ACAT inhibitors

Dec. 20, 1996

Shaman and Ono expand diabetes collaboration

Dec. 18, 1996

Pamidronate effective against skeletal complications in breast cancer patients

Dec. 18, 1996

Troglitazone hypotensive, hypoglycemic activities established in preclinical model

Dec. 18, 1996

Licenses offered for the use of IL-7 in increasing hematopoietic stem cells

Dec. 17, 1996

NIH offers glycoprotein hormone superagonists for licensing

Dec. 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...